Enjoy complimentary customisation on priority with our Enterprise License!
According to the tissue ablation industry analysis, the global tissue ablation market is anticipated to grow at a steady rate and will post a CAGR of close to 10% during the forecast period. The increasing preference for minimally invasive (MI) procedures will drive the growth prospects for the global tissue ablation market until the end of 2021. The market is witnessing an increasing rate of adoption of tissue ablation devices in various medical facilities due to the numerous advantages associated with minimally invasive procedure procedures and this factor is increasing the tissue ablation market revenue. Some of these advantages are reduced the risk of infection, minimal complications, shorter hospital stay, less pain, and faster recovery time compared to traditional open surgeries. Also, several device manufacturers are increasingly conducting training programs for medical professionals on the use of tissue ablation devices to fuel the adoption rate of these devices.
In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors contributing to growth in the market include the increasing older adult population, rise in a number of chronic diseases, and an increase in MI procedures.
The global tissue ablation market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. It has been observed that these vendors are increasingly focusing on conducting evidence-based studies to showcase the performance, efficacy, and long-term cost-effectiveness of their products.
Key vendors in this market are
Other prominent vendors in the market include Abbott Laboratories, Accuray, Acoustic Medsystems, Advanced Cardiac Therapeutics, Alcon, Alpinion Medical System, American Medical Systems, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, BSD Medical, C.R. Bard, C2 Therapeutics, CardioFocus, Chongqing Haifu Medical Technology, Conmed, CSA Medical, Cynosure, Cytyc, EDAP TMS, Elekta, Esaote, Galil Medical, Hologic, InSightec, Lumenis, Mermaid Medical, MicroPort Scientific, Microsulis Medical, Monteris Medical, Neuwave Medical, Olympus, Perseon, Philips Healthcare, Plasma Surgical, PLC Medical Systems, Profound Medical, Shenzhen Huikang Medical Apparatus, Smith & Nephew, Sonacare Medical, Spectranetics, Stryker, Terumo Medical, Theraclion, Total Vein Systems, Varian Medical, Vimecon, and Vivant Medical.
The external beam radiation therapy (EBRT) accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major applications of EBRT is to destroy cancer cells in men having high-grade prostate cancer and cancer in the lymph gland of the pelvis. This factor will positively impact the tissue ablation market value.
Based on the tissue ablation market overview, the oncology segment accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. One of the major factors responsible for the market segment’s growth is the flexibility involved in performing invasive surgeries or non-invasive surgeries depending on the type of cancerous cells.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Cost analysis
PART 07: Market segmentation by product
PART 08: Market segmentation by technology
PART 09: Market segmentation by application
PART 10: Market segmentation by end-user
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Key vendor analysis
PART 19: Appendix
PART 20: Explore Technavio
Tags: radiofrequency ablation, cardiac ablation, cardiac monitoring, mens health, healthcare market growth, healthcare segmentation analysis,
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.